RSS
 

Gynecological Cancers on The Rise

31 Jul

Scary as it may be gynecological cancers are on the rise in our region. The Gynecological Cancer Center of the University of Minnesota Medical Center, Fairview has provided a comprehensive program for women with this disease. The Clinic has achieved among the highest five year survival rates in the world. I just know that I can name six people with gynecological cancer in our region and two have died. There are others that are terminal.

Cervical cancer has gone from the second to the 13th most common causes of deaths in American women. It is thought to be from the HPA, the human papilloma virus. 14,000 women are diagnoised with it annually. It is always best to have a pap smear and cervical exam each year.

Ovarian Cancer affects  one in 70 women. There is about 26,000 women diagnosed each year in the United States, and it comes from three types: epithelial, germ cell and stromal cancers. Epithelial ovarian cancer is the most common and threatening and makes 85% of those diagnosed with the disease. Ovarian cancer often occurs in older women, with the average age of diagnosis is 62. Ovarian cancer can be familial but there are sporadic cases.

Uterine Cancer: Almost 35,000 women get this type of cancer. It is often called endometrial cancer, and is the most common gynecologic maligancy. 

Vulva Cancer affects 3,000 women a year and is often associated with HPV. There has also been a correlation with smoking. Vulva cancer has been increasing in the U.S.

We also know there are various genetic cancers associated with breast and or gynecological cancers that run in families.

We know there are cancer markers for gynecological cancers. For example, ovarian, uterine cervical and trophoblastic neoplasms are gynecological malignancies for which are there are clinical tumor markers:  These include the cancer antigen 125 or some call it CA-125,  Beta-hCG, urinary gonadotropin fragment, AFP, Inhibin, Estradiol, CEA, SCC, MIS, Topoisomerase II, 19-9, 27-29, hTER, Ferritin, and possibly others

 

Tags: , , , , ,

Comments are closed.